Literature DB >> 6416850

Diabetes mellitus, glucose tolerance and insulin response to glucose in patients with primary hyperparathyroidism before and after parathyroidectomy.

S Ljunghall, M Palmér, G Akerström, L Wide.   

Abstract

In a retrospectively analyzed series of 441 patients operated for primary hyperparathyroidism (HPT), the prevalence of diabetes mellitus was 8.2%, which was three times higher than in the unselected age-matched population. Following parathyroid surgery, the need for antidiabetic treatment was unchanged. The insulin response to an intravenous glucose load was enhanced preoperatively [95 mU/1 +/- 41 (SD)] in twenty-six prospectively studied patients compared to postoperative (65 +/- 41 mU/1) investigations (P less than 0.01). This response was inversely correlated (r = 2, P less than 0.01) to the serum phosphate concentrations but not related to calcium or parathyroid hormone levels. Postoperatively, most HPT patients experienced a deterioration of their glucose tolerance (t 1/2 for i.v. glucose 54 +/- 12 and 64 +/- 21 min, respectively, P less than 0.05), and one-third of them had pathological values at follow-up. Despite this, neither the fasting blood glucose levels nor the values for haemoglobin A1c were significantly affected.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6416850     DOI: 10.1111/j.1365-2362.1983.tb00116.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  22 in total

1.  Glucose intolerance and primary hyperparathyroidism: an unresolved relationship.

Authors:  Mishaela R Rubin; Shonni J Silverberg
Journal:  Endocrine       Date:  2012-10       Impact factor: 3.633

2.  Evaluation of glucose tolerance, insulin secretion, and insulin action in patients with primary hyperparathyroidism before and after surgery.

Authors:  R Prager; G Schernthaner; B Niederle; R Roka
Journal:  Calcif Tissue Int       Date:  1990-01       Impact factor: 4.333

3.  Parathyroidectomy Decreases Insulin Resistance Index in Patients with Primary Hyperparathyroidism.

Authors:  Cevdet Duran; Barıs Sevinc; Orkide Kutlu; Omer Karahan
Journal:  Indian J Surg       Date:  2016-01-15       Impact factor: 0.656

4.  Time to end a conservative treatment for mild hyperparathyroidism.

Authors:  J C Stevenson; J A Lynn
Journal:  Br Med J (Clin Res Ed)       Date:  1988-04-09

5.  The impact of parathyroidectomy on serum ADAMTS1, ADAMTS4 levels, insulin resistance, and subclinical cardiovascular disease in primary hyperparathyroidism.

Authors:  Melia Karakose; Mustafa Caliskan; Muyesser Sayki Arslan; Taner Demirci; Suleyman Karakose; Erman Cakal
Journal:  Endocrine       Date:  2016-11-14       Impact factor: 3.633

6.  Parathyroid hormone is associated with incident diabetes in white, but not black adults: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  J P Reis; E Selvin; J S Pankow; E D Michos; C M Rebholz; P L Lutsey
Journal:  Diabetes Metab       Date:  2016-01-15       Impact factor: 6.041

Review 7.  Derangement of glucose metabolism in hyperparathyroidism.

Authors:  M Procopio; G Borretta
Journal:  J Endocrinol Invest       Date:  2003-11       Impact factor: 4.256

8.  Primary hyperparathyroidism: epidemiology, diagnosis and clinical picture.

Authors:  S Ljunghall; P Hellman; J Rastad; G Akerström
Journal:  World J Surg       Date:  1991 Nov-Dec       Impact factor: 3.352

9.  Evidence against a direct role of klotho in insulin resistance.

Authors:  Olivier Lorenzi; Christelle Veyrat-Durebex; Claes B Wollheim; Pascal Villemin; Françoise Rohner-Jeanrenaud; Anne Zanchi; Ulrich M Vischer; Ulrich Vischer
Journal:  Pflugers Arch       Date:  2009-09-13       Impact factor: 3.657

10.  Insulin sensitivity in subjects with secondary hyperparathyroidism and the effect of a low serum 25-hydroxyvitamin D level on insulin sensitivity.

Authors:  E Kamycheva; R Jorde; Y Figenschau; E Haug
Journal:  J Endocrinol Invest       Date:  2007-02       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.